|
C13ORF23 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.244400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.041500E-03 |
| Normal-vs-Stage2 |
3.420200E-01 |
| Normal-vs-Stage3 |
1.132970E-01 |
| Normal-vs-Stage4 |
1.609590E-02 |
| Stage1-vs-Stage2 |
5.911600E-01 |
| Stage1-vs-Stage3 |
7.807000E-01 |
| Stage1-vs-Stage4 |
6.611400E-01 |
| Stage2-vs-Stage3 |
8.022000E-01 |
| Stage2-vs-Stage4 |
4.707800E-01 |
| Stage3-vs-Stage4 |
5.380400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.338400E-03 |
| Normal-vs-AfricanAmerican |
3.800800E-01 |
| Normal-vs-Asian |
1.613770E-02 |
| Caucasian-vs-AfricanAmerican |
2.052400E-01 |
| Caucasian-vs-Asian |
2.101800E-01 |
| AfricanAmerican-vs-Asian |
4.955600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.563600E-04 |
| Normal-vs-Female |
7.206000E-01 |
| Male-vs-Female |
3.383900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.131900E-02 |
| Normal-vs-Extreme_Weight |
1.37550000001152E-06 |
| Normal-vs-Obese |
8.266300E-02 |
| Normal-vs-Extreme_Obese |
6.635400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.771630E-01 |
| Normal_Weight-vs-Obese |
6.298600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.787600E-01 |
| Extreme_Weight-vs-Obese |
4.884800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.833800E-01 |
| Obese-vs-Extreme_Obese |
8.136800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.506000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.919200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.189300E-04 |
| Normal-vs-Age(81-100Yrs) |
4.45240000002123E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.321600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.001400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.916200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.041600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.981200E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.472200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.772100E-04 |
| Normal-VS-Type2 PRCC |
1.119810E-02 |
| Normal-VS-KIRP CIMP |
3.356300E-02 |
| Normal-VS-Unclassified PRCC |
7.733600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.226000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.316600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.099900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.850800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.151800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.031600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.982800E-03 |
| Normal-vs-N1 |
9.015600E-01 |
| Normal-vs-N2 |
2.553300E-04 |
| N0-vs-N1 |
5.116100E-02 |
| N0-vs-N2 |
2.484000E-01 |
| N1-vs-N2 |
2.646500E-02 |
|
|
